Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy
Background The clinical importance of intraprocedural stent thrombosis (IPST) during percutaneous coronary intervention in the contemporary era of potent oral P2Y12 inhibitors is not established. The aim of this study was to assess IPST and its association with clinical outcome in patients with myoc...
Guardado en:
Autores principales: | Sofia Bergman, Moman A. Mohammad, Stefan K. James, Oskar Angerås, Henrik Wagner, Jens Jensen, Fredrik Scherstén, Ole Fröbert, Sasha Koul, David Erlinge |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c28dbdfe0e249449a24ae1364a208af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Case of Stent Fracture and Very Late Stent Thrombosis 15 Months after Drug-Eluting Stent Implantation
por: A Ghaemian,, et al.
Publicado: (2009) -
Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
por: Sadeq Tabatabai, et al.
Publicado: (2021) -
Real-world registry of the durable Angiolite fluoroacrylate polymer-based sirolimus-eluting stent: the EPIC02 – RANGO study
por: Armando Pérez de Prado, et al.
Publicado: (2021) -
Anti-platelet drugs, pharmacogenomics and stent thrombosis: What’s new?
por: John Benjamin
Publicado: (2017) -
Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
por: Khaled Alsayed
Publicado: (2020)